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ORIGINAL ARTICLE
A MCh Test Pre-post Esophageal Acidification in Detecting
GER-related Asthma
Roberto Walter Dal Negro,1,∗ Silvia Tognella,1 Claudio Micheletto, M.D.,1 Marco Sandri,2
and Massimo Guerriero3
1Ospedale Orlandi, Lung Department, Bussolengo, Italy
2University of Brescia, Department of Quantitative Methods, Brescia, Italy
3University of Verona, ESI Dept, Verona, Italy
The direct effect of gastro-esophageal reflux (GER) on lung function is still debated. Objective. To investigate the role of esophageal acidification
in affecting airway response to MCh in GER-related versus atopic asthmatics and to assess specificity and sensitivity of events. Subjects. A total of 56
never-smoking, mild asthmatics: 27 non-atopic asthmatics and acid GER (GER+ve) and 29 atopic asthmatics without any GER (GER–ve). Methods.
Each subject performed an MCh challenge in baseline (MChb), and 30 minutes after an acid drink (125 mL at pH = 2; MChac), one day apart.
PD20FEV1 MChb and MChac were compared by estimating the area under the ROC curve (AU-ROC). Results. GER+ve and GER-ve subjects (well
matched in baseline) had a different duration of esophageal acid contact (24-hour monitoring; pH-24h AU4), and PD20FEV1 MChac (both p <0.001).
AU-ROC was 86.3% (76% to 97%, 95%CI). Sensitivity and specificity of changes were 82.8% (72.9% to 92.7%, 95%CI) and 85.2% (75.9% to
94.5%, 95%CI), respectively. The difference in MCh threshold that maximized both the sensitivity and specificity level was 100 µg. Conclusions.
The esophageal acidification identified GER-related asthma with a good level of both sensitivity and specificity by enhancing the MCh response only
in the presence of acid GER. Data are supporting the effectiveness of this procedure for clinical purposes.
Keywords gastro-oesophageal reflux, bronchial asthma, bronchial hyperreactivity, lung function, GER-related asthma, oesophageal acidification
Introduction
The esophagus and the airways can mutually interact
through several mechanisms (1) through their anatomical
proximity and common embryology.
Acid Gastroesophageal Reflux (GER) represents a diges-
tive dysfunction that can frequently occur also in normal
people at a some extent, but it is not surprising that GER oc-
currence frequently combines with the onset of one or more
respiratory symptoms of different severity and relevant clin-
ical impact (2–6). In these circumstances, cough and wheez-
ing represent the most frequent respiratory complaints, which
are usually related spontaneously to GER occurrence in the
patient.
The prevalence of respiratory manifestations of GER of-
ten remains undefined because the cause-effect relationship
between the occurrence of GER events and the onset of
respiratory-related symptoms proves really difficult to as-
sess, and frequently the patient’s history still remains the
unique feature of some clinical value in these cases (7). Un-
fortunately, usual indices of lung function (namely, PEFR
measurements, spirometrical lung volumes and flows, air-
way resistance) prove too poor sensitivity and specificity in
assessing respiratory dysfunctions related to acid GER (8),
and GER-induced respiratory troubles can actually occur al-
though pulmonary function is normal (6, 9).
Moreover, the usual measure of bronchial hyperreactivity
(BHR) to non-specific stimuli (namely, histamine or metha-
∗Corresponding author: Dr Roberto Walter Dal Negro, Ospedale Or-
landi, Lung Dept., Via Ospedale 2, Bussolengo, 37012 Italy; E-mail:
rdalnegro@ulss22.ven.it
choline) showed a poor diagnostic power in the presence of
GER (10–13).
In 1986, Herve et al. proved that the repeated stimulation
of esophageal acid-sensitive receptors can interact with the
bronchomotor tone and for the first time suggested that the
presence of an hyperacidic esophageal environment can en-
hance bronchial hyperresponsiveness to non-specific stimuli
(14).
The aim of the present study was to investigate non-
invasively the effects of a standardized acid esophageal chal-
lenge on the bronchial response to MCh in asthma patients
with and without acid GER to assess both the specificity
and the sensitivity of respiratory changes observed and to
calculate the potential diagnostic role of this procedure in
identifying patients suspected for acid GER-related asthma.
Materials and Methods
Fifty-six never-smoking mild asthmatics (basal FEV1 ≥
80% predicted) in stable conditions were recruited after their
informed written consent: 27 subjects (7 males) were non-
atopic asthmatics with a symptomatic and pathologic acid
GER, which was first suspected by the recurrence of specific
clinical signs (namely, acid regurgitation and retrosternal
burning ≥3 days/week) and then confirmed by a 24-hour
gastro-esophageal pH monitoring, while the remaining
29 subjects (5 males) were atopic asthmatics without any
clinical sign of acid GER occurrence, being the presence of
GER excluded by means of the pH monitoring procedure.
The atopic condition had been confirmed or excluded on
the basis of patients’ clinical history, their total IgE level
measured in blood; their prick test (to a panel of the 21 most
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frequent allergen classes), and the measurement of corre-
sponding specific IgE (RAST).
All subjects were regularly taking only inhaled steroids for
at least 24 weeks: their daily doses ranged from 400 to 500
µg BDP (or equivalent), and their compliance to treatment
was good (≥75% prescribed dose). Short-acting β2 agonists
were the only rescue medication permitted during the study.
Exclusion criteria were basal FEV1 <80% predicted; unsta-
ble bronchial obstruction (PEFR variability >30%); frequent
use of short-acting β2 agonists in the last 4 weeks; regular
use of high doses of ICS; use of PPIs and/or anti H2 com-
pounds ≥2 days/week in the last 4 weeks; pregnant or lac-
tating women; systemic concomitant diseases; neoplasms;
mental limitations.
Lung function was basally assessed by a spirometric test
(Masterscreen; Vyasis-Jaeger; Hoechberg; Germany); FEV1
was expressed as an absolute value (L) and as % predicted
(CECA 1993, in the range 18–70 years) (15). The bronchial
response to MCh was first assessed in baseline, and re-
sults were expressed in micrograms MCh needed for a 20%
decrease of FEV1 from its basal value (PD20 FEV1). The
bronchial challenge was performed by doubling MCh doses
(ranging 50 to 3,150 µg) via APS System (Vyasis-Jaeger;
Hoechberg; Germany) up to the PD20 FEV1 (16).
After a 24-hour interval, and at an average of 3 hours before
lunch, each subject repeated the MCh challenge 30′ following
the esophageal acidification (namely, after drinking 125 mL
of a standardized acid solution at a controlled pH = 2) and
the corresponding bronchial response was compared with
that assessed in baseline, before the acid challenge.
In all subjects, the presence of a pathologic acid GER
had been previously (in the previous 12 weeks) detected
(e.g., confirmed or excluded) by means of a 24-hour gastro-
esophageal pH monitoring: A combined monocristant an-
timony catheter was used with a pressure sensor to locate
the LES (Digitrapper MKIII; Synectics Med., Stockolm,
Sweden), and the diagnostic DeMeester’s criteria were as-
sumed (17). In the present study, the result of the 24-hour pH
monitoring was synthetically expressed as “AU under pH 4”
(AU4– area under the curve of pH4), such as the parameter
that indicates the extent of the acid contact at a pH<4 into
the esophagus (17).
The overall patients’ sample was then divided into two
subgroups: the patients in whom presence of a pathologic
acid GER was documented (GER +ve; n = 27) and those
without any significant registration of GER events (GER –ve;
n = 29).
Statistics
The two subgroups of patients were compared for age;
basal weight; height; BMI; pH 24-hour AU4; absolute FEV1
value; basal PD20 FEV1 to MCh in baseline (MChb), and
PD20 FEV1 to MCh after the acid drink (MChac); Student’s
t test was used to compare corresponding means ± SD, and
p <0.05 was assumed as the minimal level for statistical
significance.
As ROC (Receiver Operating Characteristic) curves have
been widely accepted as the standard method for describing
and comparing the accuracy of diagnostic medical proce-
dures (18), the accuracy of a diagnostic test based on the
absolute difference between PD20 MChb and PD20MChac as
assessed in the two subgroups of subjects was checked by the
Table 1.—Demographics, mean basal FEV1; PD20 FEV1 MChb; PD20 FEV1,
MChac; pH-24h AU4 ± sd, and the corresponding t test p values.
GER +ve GER−ve p
n 27 29
Sex (n and % males) 7 (25.9%) 5 (17.2%) 0.429†
Age (y) 41.7 ± 13.8 41.6 ± 14.9 ns
Weight (kg) 63.5 ± 14.4 61.2 ± 10.0 ns
Height (cm) 162.7 ± 7.5 163.4 ± 6.8 ns
BMI 24.1 ± 5.9 23.0 ± 3.8 ns
FEV1 (l) 2.8 ± 0.7 3.0 ± 0.6 ns
PD20 MCh b(µg) 1607.5 ± 882.3 1965.0 ± 610.4 ns
PD20 MChac (µg) 787.8 ± 751.1 2197.1 ± 685.4 <0.001
pH-24-hour AU4 114.1 ± 94.7 10.8 ± 7.4 <0.001
†= Pearson’s chi-square test.
estimate of the area under the ROC curve (AU ROC), with a
95% confidence interval.
In the present paper, the area under the ROC curve was
expressed in percentage of the total area, and the estimator’s
standard error was also indicated. Analyses were undertaken
by using Stata 8.0 (19).
Results
Descriptive statistics (means ± SD) of all variables ob-
served in the two subgroups of subjects are reported in Table
1, together with the corresponding significance (p value) for
statistical comparisons.
GER +ve and GER −ve subjects were well matched for
sex, age, weight, height, and body mass index (BMI). They
also were comparable in terms of their basal lung function
(namely FEV1, and basal bronchial response to MCh -MChb)
(Table 1).
Nevertheless, the subgroups were different in terms of pH-
24h AU4 (the extent of esophageal acid contact at pH < 4
during the 24-hour monitoring) and of their response to MCh
after the acid esophageal challenge (MChac) (both p <0.001)
(Table 1).
The area under the ROC curve was = 0.863 (0.055 esti-
mator’s standard error); or, 86.3% of the total area available
under the ROC, being 76% to 97% of the corresponding 95%
CI (Figure 1).
Figure 1.—The area under the ROC curve for the diagnostic procedure. The
AUC estimation of the ROC curve for the diagnostic procedure is (0.86 CI 95%
[0.76–0.97]).
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Table 2.—Classification data corresponding to the maximized values for both
sensitivity and specificity of the procedure; absolute decrease in PD20 FEV1
MCh before and after the acid esophageal challenge was = 100 µg MCh.
Diagnostic test Groups
GER+ GER−
pos. 23 5
neg. 4 24
Total 27 29
True D defined as group ∼= 1 [95% CI]
Sensitivity Pr(+| D) 82.76% 72.87% 92.65%
Specificity Pr(−| ∼D) 85.19% 75.88% 94.49%
Positive predictive value Pr(D|+) 85.71% 76.55% 94.88%
Negative predictive value Pr(∼D| −) 82.14% 72.11% 92.17%
Values calculated for both sensitivity and specificity of
measures were 82.8% (72.9–92.7%, 95% CI) and 85.2%
(75.9–94.5%, 95% CI), respectively. Moreover, values for
both sensitivity and specificity proved to change according
to the extent of the absolute difference between the PD20
MChb and the PD20 MChac threshold observed (such as the
values for PD20 FEV1 MCh calculated before and after the
acid esophageal challenge). The corresponding curvilinear
trends were obtained and then compared.
The decrease in PD20 FEV1 MCh that enabled to max-
imize both the sensitivity and the specificity levels of the
diagnostic procedure was = 100 µg from baseline (Table 2).
Figure 2 shows sensitivity and specificity curves for all abso-
lute differences in PD20FEV1 MChb and PD20FEV1 MChac
as calculated in the two different subgroups of subjects. In
agreement with data reported in Table 2, it is clearly shown
that the two curves intercept in correspondence of a 100-µg
MCh difference between the basal and the post-acid MCh
condition.
All patients performed the two MCh challenges without
any discomfort.
Discussion
The occurrence of respiratory symptoms in asthma patients
with digestive disorders (namely, acid GER) is a frequent
Figure 2.—Sensitivity and specificity curves for all absolute differences in
PD20 FEV1 MCh calculated in the two different subgroups of subjects.
occurrence, although the limits of this relationship are still
debated, as well as the direct and causative role of esophageal
acidification in inducing significant and specific changes in
lung function (12, 13). Actually, while new technologies
contributed substantially in providing some reliable meth-
ods for investigating upper digestive tract dysfunctions more
specifically in the last decade (and the 24-hour pH monitor-
ing was regarded as the golden standard), usual pulmonary
lung function tests did not contribute as effectively in dis-
criminating patients with respiratory disorders when they
were related to the presence of acid gastro-esophageal reflux
(10–13).
In previous studies, the esophageal acid perfusion was
shown to cause only a 0.2L decrease in vital capacity (20),
while peak expiratory flow rate (PEFR) was found to de-
crease in asthmatics with or without GER (21). Conversely,
a significant reduction in PEFR was observed only when both
the esophageal and the tracheal acidification were performed,
with the effects on PEFR of the sole esophageal acidification
clinically negligible (22, 23).
From a general point of view, although episodic expe-
riences (in both experimental and clinical studies) proved
the effective role of esophageal acidification in inducing
a transient airway obstruction (10, 11, 24), the assessment
of the direct and causative role of esophageal acidification
(spontaneous or induced) in determining a measurable air-
way involvement (such as narrowing) still represents a true
diagnostic challenge.
When the diagnostic role of the measure of airway re-
sponse to MCh also was investigated from this point of
view in asthma subjects with gastroesophageal reflux, MCh-
induced airway narrowing was shown to coexist with longer
lasting periods of reflux as compared with the baseline condi-
tion (25), although the sole basal assessment of non-specific
BHR did not consent any precise identification of a specific
and reliable GER-induced pattern of lung function response
in these cases (26, 28).
Data of the present paper are in good agreement with this
vision as both the basal spirometrical measurements and the
basal value for MCh threshold proved not specific enough to
discriminate acid GER +ve asthma subjects from controls.
Conversely, the enhancement of the original bronchial re-
sponse to non-specific stimuli by triggering esophageal acid-
sensitive receptors according to the Herve’s hypothesis (14)
can now be regarded as interesting scientific evidence sug-
gesting the true diagnostic value of the assessment of res-
piratory effects due to induced esophageal acidification in
asthma patients with acid GER.
A few years ago, preliminary data from a controlled study
carried out in a selected sample of very mild, non-atopic
asthmatics with acid GER, originally unresponsive to MCh,
showed that their basal bronchial response to MCh was sys-
tematically and substantially affected (such as enhanced)
when the non-specific bronchial challenge had been repeated
after the esophageal stimulation with an acid drink at a pH
= 2, which proved to act as an effective trigger per se (29).
These pivotal data were strictly fitting with the Herve’s hy-
pothesis and also confirmed the results obtained in a previous
similar study in which airway reactivity to histamine was as-
sessed in asthma subjects with GER according to a double
blind controlled design (30).
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Although this pattern of respiratory response to esophageal
acid stimulation was confirmed in different sequential sets
of subjects with comparable characteristics (personal data
on file), the rigorous assessment of both sensitivity and
specificity of parametrical changes achievable following
esophageal acidification was needed, and a strict statistical
design was required to check the potential diagnostic role of
this investigational procedure.
Data of the present study are providing the first evidence
to our knowledge of the high discrimination power of mea-
surements of bronchial response to MCh when performed
and compared before and after a standardized esophageal
acid challenge, with the AU ROC calculated for differences
higher than 86%.
Actually, a diagnostic procedure should be regarded as
characterized by a good discrimination power only when the
corresponding AU ROC is greater than 80%, the “discrimina-
tion power” reached in the present investigational procedure.
Based on the PD20 MChac- MChb comparison, it is highly
probable that the misclassification found by that diagnostic
test performed in a randomly selected patient from one of the
two subsets of subjects (namely from GER+ve subjects) is
lower than that observed in the subjects of the other group.
In other words, as the pattern of lung function that is ob-
tained in response to the esophageal acid challenge (and
the corresponding extent of non-specific BHR) confirms as
quite peculiar in GER+ve asthma subjects only, it would be
suggested that the effective presence of acid in lower esoph-
agus, which was induced by the acid drink in our model, can
directly affect airway reactivity substantially. This demon-
strates that this kind of measurement can be of true and
effective diagnostic value when performed according to a
strict protocol of investigation.
Present data provide the first contribution to our knowl-
edge aimed to the standardization of a non-invasive diagnos-
tic procedure oriented to the detection and assessment in a
clinical setting of changes in lung function specifically due to
esophageal acidification in asthma patients suspected of the
presence of acid GER. Actually. the method proves promis-
ing because it is effective enough in clinical terms, easy to
perform, of low cost, and without any significant discomfort
for the patients.
Finally, although the MCh challenge repeated after
esophageal acidification is suggested as a sensitive and spe-
cific procedure for detecting and discriminating GER-related
asthma, further studies are needed to confirm results of
the present methodological approach. These studies will be
aimed at investigating the pattern (peculiar indeed) of acid-
induced hyperreactive response of airways in subjects with
acid GER-related asthma.
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